The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: Contemporary estimates of average years of life lost

April K S Salama, Nicole De Rosa, Randall P. Scheri, James E. Herndon, Douglas Tyler, Jennifer Marcello, Scott K. Pruitt, Amy P. Abernethy

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives: Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients. Methods: MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed. Results: Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades. Conclusions: AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.

Original languageEnglish (US)
Pages (from-to)637-641
Number of pages5
JournalCancer Investigation
Volume30
Issue number9
DOIs
StatePublished - Nov 2012
Externally publishedYes

Fingerprint

Melanoma
Linear Models
Databases
Research
Neoplasms

Keywords

  • Life expectancy
  • Melanoma
  • Mortality
  • Potential years of life lost
  • Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma : Contemporary estimates of average years of life lost. / Salama, April K S; Rosa, Nicole De; Scheri, Randall P.; Herndon, James E.; Tyler, Douglas; Marcello, Jennifer; Pruitt, Scott K.; Abernethy, Amy P.

In: Cancer Investigation, Vol. 30, No. 9, 11.2012, p. 637-641.

Research output: Contribution to journalArticle

Salama, April K S ; Rosa, Nicole De ; Scheri, Randall P. ; Herndon, James E. ; Tyler, Douglas ; Marcello, Jennifer ; Pruitt, Scott K. ; Abernethy, Amy P. / The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma : Contemporary estimates of average years of life lost. In: Cancer Investigation. 2012 ; Vol. 30, No. 9. pp. 637-641.
@article{90bd34012fad4e5fb5983c4c02ccffc9,
title = "The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: Contemporary estimates of average years of life lost",
abstract = "Objectives: Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients. Methods: MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed. Results: Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades. Conclusions: AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.",
keywords = "Life expectancy, Melanoma, Mortality, Potential years of life lost, Survival",
author = "Salama, {April K S} and Rosa, {Nicole De} and Scheri, {Randall P.} and Herndon, {James E.} and Douglas Tyler and Jennifer Marcello and Pruitt, {Scott K.} and Abernethy, {Amy P.}",
year = "2012",
month = "11",
doi = "10.3109/07357907.2012.726387",
language = "English (US)",
volume = "30",
pages = "637--641",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma

T2 - Contemporary estimates of average years of life lost

AU - Salama, April K S

AU - Rosa, Nicole De

AU - Scheri, Randall P.

AU - Herndon, James E.

AU - Tyler, Douglas

AU - Marcello, Jennifer

AU - Pruitt, Scott K.

AU - Abernethy, Amy P.

PY - 2012/11

Y1 - 2012/11

N2 - Objectives: Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients. Methods: MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed. Results: Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades. Conclusions: AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.

AB - Objectives: Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients. Methods: MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed. Results: Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades. Conclusions: AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.

KW - Life expectancy

KW - Melanoma

KW - Mortality

KW - Potential years of life lost

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84867721516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867721516&partnerID=8YFLogxK

U2 - 10.3109/07357907.2012.726387

DO - 10.3109/07357907.2012.726387

M3 - Article

C2 - 23020583

AN - SCOPUS:84867721516

VL - 30

SP - 637

EP - 641

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 9

ER -